Literature DB >> 21743780

THE MULTIFACETED ROLE OF T CELL-MEDIATED IMMUNITY IN PATHOGENESIS AND RESISTANCE TO MYCOPLASMA RESPIRATORY DISEASE.

Nicole A Dobbs1, Adam N Odeh, Xiangle Sun, Jerry W Simecka.   

Abstract

Mycoplasma respiratory diseases have a significant impact on the economy, health and wildlife. The hallmark of these diseases is the persistence of the mycoplasma infections and chronic inflammatory responses associated with the airways. There is still much that needs to be understood about the immune mechanisms involved in mycoplasma disease and resistance from infection. It is clear that immune responses can contribute to the generation of inflammatory lesions in mycoplasma respiratory disease, as well as provide protection from infection and extrapulmonary dissemination of the organisms. The evolution of this lung disease is under the control innate immune mechanisms and the contrasting effects of different T cell populations. The mechanisms of immunity involved in mycoplasma diseases are multifaceted, and a fascinating story of its complexity is being uncovered. Research in mycoplasma respiratory diseases have underscored the idea that immunity along the respiratory tract against infectious agents is a dynamic process and involves a network of cellular and cytokine signals that determine the type of responses generated, and ultimately, the outcome of infection. The aim of this article is to present on overview of our work on mycoplasma disease and immunity, focusing on the interactions and regulation of T cell responses that influence disease pathogenesis. We will first provide an overview of immune mechanisms involved in controlling infection and participate in the generation of T cell responses, and the role of T cell populations in generating protection and contributing to lesion development will be discussed.

Entities:  

Year:  2009        PMID: 21743780      PMCID: PMC3131222     

Source DB:  PubMed          Journal:  Curr Trends Immunol        ISSN: 0972-4567


  171 in total

Review 1.  Ligands for natural killer cell receptors: redundancy or specificity.

Authors:  A Cerwenka; L L Lanier
Journal:  Immunol Rev       Date:  2001-06       Impact factor: 12.988

2.  IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection.

Authors:  Mahboob H Qureshi; Allen G Harmsen; Beth A Garvy
Journal:  J Immunol       Date:  2003-01-15       Impact factor: 5.422

3.  Resistance to Mycoplasma pulmonis mediated by activated natural killer cells.

Authors:  W C Lai; M Bennett; S P Pakes; V Kumar; D Steutermann; I Owusu; A Mikhael
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

Review 4.  Comparative pathogenicity of Mycoplasma bovis and Mycoplasma dispar for the respiratory tract of calves.

Authors:  C J Howard; L H Thomas; K R Parsons
Journal:  Isr J Med Sci       Date:  1987-06

5.  Serum antibody does not account for differences in the severity of chronic respiratory disease caused by Mycoplasma pulmonis in LEW and F344 rats.

Authors:  J W Simecka; J K Davis; G H Cassell
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

6.  Role of Th2 responses in the development of allergen-induced airway remodelling in a murine model of allergic asthma.

Authors:  Masato Komai; Hiroyuki Tanaka; Taisei Masuda; Koichi Nagao; Masayuki Ishizaki; Masatsugu Sawada; Hiroichi Nagai
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

7.  Long-term epidemiology of infections with Mycoplasma pneumoniae.

Authors:  H M Foy; G E Kenny; M K Cooney; I D Allan
Journal:  J Infect Dis       Date:  1979-06       Impact factor: 5.226

8.  Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance.

Authors:  Xuefang Cao; Sheng F Cai; Todd A Fehniger; Jiling Song; Lynne I Collins; David R Piwnica-Worms; Timothy J Ley
Journal:  Immunity       Date:  2007-10-04       Impact factor: 31.745

9.  Allergen-induced accumulation of airway dendritic cells is supported by an increase in CD31(hi)Ly-6C(neg) bone marrow precursors in a mouse model of asthma.

Authors:  Leonie S van Rijt; Jan-Bas Prins; Pieter J M Leenen; Kris Thielemans; Victor C de Vries; Henk C Hoogsteden; Bart N Lambrecht
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

10.  Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids.

Authors:  G M Möller; S E Overbeek; C G Van Helden-Meeuwsen; J M Van Haarst; E P Prens; P G Mulder; D S Postma; H C Hoogsteden
Journal:  Clin Exp Allergy       Date:  1996-05       Impact factor: 5.018

View more
  13 in total

1.  Interleukin-17A Exacerbates Disease Severity in BALB/c Mice Susceptible to Lung Infection with Mycoplasma pulmonis.

Authors:  Maximillion T Mize; Xiangle L Sun; Jerry W Simecka
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

2.  Autoimmune-Disease-Prone NOD Mice Help To Reveal a New Genetic Locus for Reducing Pulmonary Disease Caused by Mycoplasma pulmonis.

Authors:  Glenn F Browning; Thomas C Brodnicki; Nadeeka K Wawegama; Philip F Markham; Colleen M Elso; Anna Kanci; Marc S Marenda
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

3.  Antigen-pulsed bone marrow-derived and pulmonary dendritic cells promote Th2 cell responses and immunopathology in lungs during the pathogenesis of murine Mycoplasma pneumonia.

Authors:  Nicole A Dobbs; Xia Zhou; Mark Pulse; Lisa M Hodge; Trenton R Schoeb; Jerry W Simecka
Journal:  J Immunol       Date:  2014-06-27       Impact factor: 5.422

Review 4.  Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs.

Authors:  Dominiek Maes; Filip Boyen; Bert Devriendt; Peter Kuhnert; Artur Summerfield; Freddy Haesebrouck
Journal:  Vet Res       Date:  2021-05-08       Impact factor: 3.683

5.  Transfer of Mycoplasma hyopneumoniae-specific cell mediated immunity to neonatal piglets.

Authors:  Bert Devriendt; Dominiek Maes; Evelien Biebaut; Lisa Beuckelaere; Filip Boyen; Freddy Haesebrouck; Charles-Oliver Gomez-Duran
Journal:  Vet Res       Date:  2021-06-30       Impact factor: 3.683

6.  Regulatory CD4+CD25+ T Cells Dampen Inflammatory Disease in Murine Mycoplasma Pneumonia and Promote IL-17 and IFN-γ Responses.

Authors:  Adam N Odeh; Jerry W Simecka
Journal:  PLoS One       Date:  2016-05-13       Impact factor: 3.240

7.  Systems Immunology Characterization of Novel Vaccine Formulations for Mycoplasma hyopneumoniae Bacterins.

Authors:  Anneleen M F Matthijs; Gaël Auray; Virginie Jakob; Obdulio García-Nicolás; Roman O Braun; Irene Keller; Rémy Bruggman; Bert Devriendt; Filip Boyen; Carlos A Guzman; Annelies Michiels; Freddy Haesebrouck; Nicolas Collin; Christophe Barnier-Quer; Dominiek Maes; Artur Summerfield
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

8.  Efficacy of three innovative bacterin vaccines against experimental infection with Mycoplasma hyopneumoniae.

Authors:  Anneleen Marguerite Filip Matthijs; Gaël Auray; Filip Boyen; Alexandra Schoos; Annelies Michiels; Obdulio García-Nicolás; Güliz Tuba Barut; Christophe Barnier-Quer; Virginie Jakob; Nicolas Collin; Bert Devriendt; Artur Summerfield; Freddy Haesebrouck; Dominiek Maes
Journal:  Vet Res       Date:  2019-11-08       Impact factor: 3.683

9.  Susceptibility Analysis in Several Mouse Strains Reveals Robust T-Cell Responses After Mycoplasma pneumoniae Infection in DBA/2 Mice.

Authors:  Shigeyuki Tamiya; Eisuke Yoshikawa; Koichiro Suzuki; Yasuo Yoshioka
Journal:  Front Cell Infect Microbiol       Date:  2021-01-13       Impact factor: 5.293

Review 10.  Biological functions of IL-17-producing cells in mycoplasma respiratory infection.

Authors:  Ying Luo; Cheng Li; Zhou Zhou; Zhande Gong; Cuiming Zhu; Aihua Lei
Journal:  Immunology       Date:  2021-05-19       Impact factor: 7.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.